There was no significant difference in the expression levels of NLRP3 and caspase-1 between DM and PM patients, possibly due to NLRP3 inflammasomes being involved in local muscle inflammation in DM/PM, with the released IL-1β/IL-18 possibly exacerbating disease progression (64). This evidence concerns the gene NLRP3 and dermatomyositis.